E.A. van de Graaf

1.9k citations

42 papers · 1.2k indexed · 1 hit paper · h-index 17

Impact in

Transplantation top 1%
- Renal Transplantation Outcomes and Treatments
Pulmonary and Respiratory Medicine top 5%
- Cystic Fibrosis Research Advances
- Neonatal Respiratory Health Research

Papers in

Transplantation 14
- Renal Transplantation Outcomes and Treatments 13
Surgery 23
- Transplantation: Methods and Outcomes 22

Co-authors: T.A. Out H M Jansen Johanna M. Kwakkel‐van Erp Harry Heijerman Jan Meulenbelt Maaike A. Sikma Marianne C. Verhaar Jozef Kesecioğlu
Journals: Journal of Cystic Fibrosis (7 papers)Frontiers in Immunology (4 papers)The Journal of Heart and Lung Transplantation (4 papers)American Journal of Transplantation (3 papers)Clinical & Experimental Immunology (3 papers)
Partner nations: Netherlands Germany Belgium

In The Last Decade

E.A. van de Graaf

42 papers receiving 1.2k citations

Hit Papers

align trajectories log scale

Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis 2016 · 401 citations

Peers

Countries citing papers authored by E.A. van de Graaf

Since Specialization

Citations

This map shows the geographic impact of E.A. van de Graaf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.A. van de Graaf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.A. van de Graaf more than expected).

Fields of papers citing papers by E.A. van de Graaf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.A. van de Graaf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.A. van de Graaf. The network helps show where E.A. van de Graaf may publish in the future.

Co-authorship network

The 25 scholars most cited alongside E.A. van de Graaf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E.A. van de Graaf Line = papers co-authored together E.A. van de Graaf links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Resting energy expenditure in cystic fibrosis patients decreases after lung transplantation, which improves applicability of prediction equations for energy requirement Journal of Cystic Fibrosis ·Hyen-Gyoo Shin, Timon 西蒙恩;Uatioa, Nicole M. de Roos, E.A. van de Graaf, Harry Heijerman	2020	5
2	A Single Nucleotide C3 Polymorphism Associates With Clinical Outcome After Lung Transplantation Frontiers in Immunology ·Hessam Ahmadi, А А Кочурин, E.A. van de Graaf, Jessica van Setten, Marjori Klinczak, Sandra Prgomet, Grafe	2019	9
3	The Autoimmune-Associated Single Nucleotide Polymorphism Within PTPN22 Correlates With Clinical Outcome After Lung Transplantation Frontiers in Immunology ·А А Кочурин, Jessica van Setten, E.A. van de Graaf, Marjori Klinczak, Hessam Ahmadi, Johanna M. Kwakkel‐van Erp, Sandra Prgomet, C. Erik Hack, Grafe	2019	4
4	Correlation between individual clinical responses and forskolin-induced swelling of paired intestinal organoids upon CFTR modulator treatment Pediatric Pulmonology ·Gitte Berkers, Johanna F. Dekkers, Evelien Kruisselbrink, Annelotte M. Vonk, Alessandra Pusceddu, Laura Ruiz Mondragón, Christèle Fraïssé, 合馬慎二, Karin M. de Winter‐de Groot, Hubertus G.M. Arets, Lilian S. Abu Hadba, E.A. van de Graaf, Christof J. Majoor, Gerard H. Koppelman, Jolt Roukema, Marleen Bakker, Katherine Noemi Sanchez Estrada, Cornelis K. van der Ent	2017	1
5	Serum miRNAs as potential biomarkers for the bronchiolitis obliterans syndrome after lung transplantation Transplant Immunology ·А А Кочурин, Marzia Rossato, E.A. van de Graaf, Johanna M. Kwakkel‐van Erp, Alfonso Gonzales, Henny G. Otten	2017	16
6	Antibodies against Apoptotic Cells Present in End-stage Lung Disease Patients Do Not Correlate with Clinical Outcome after Lung Transplantation Frontiers in Immunology ·А А Кочурин, E.A. van de Graaf, Hessam Ahmadi, Sandra Prgomet, Johanna M. Kwakkel‐van Erp, C. Erik Hack, Henny G. Otten	2017	3
7	High tacrolimus blood concentrations early after lung transplantation and the risk of kidney injury European Journal of Clinical Pharmacology ·Maaike A. Sikma, Claudine C. Hunault, E.A. van de Graaf, Marianne C. Verhaar, Jozef Kesecioğlu, Dylan W. de Lange, Jan Meulenbelt	2017	55
8	Association between a Single Donor TARC/CCL17 Promotor Polymorphism and Obstructive Chronic Lung Allograft Dysfunction after Lung Transplantation Frontiers in Immunology ·А А Кочурин, Jessica van Setten, E.A. van de Graaf, Marjori Klinczak, Hessam Ahmadi, Sandra Prgomet, C. Erik Hack, Grafe	2017	1
9	A Multicenter Study on Long-Term Outcomes After Lung Transplantation Comparing Donation After Circulatory Death and Donation After Brain Death American Journal of Transplantation ·P. J. Fordham, Bart Luijk, Rogier A.S. Hoek, E.A. van de Graaf, Erik A.M. Verschuuren, Caroline Van De Wauwer, Jos A. Bekkers, R. Meijer, Wim van der Bij, Michiel E. Erasmus	2017	39
10	β₂-Adrenergic receptor agonists activate CFTR in intestinal organoids and subjects with cystic fibrosis European Respiratory Journal ·Milad Ali Badi, Gitte Berkers, Johanna F. Dekkers, Domenique D. Zomer-van Ommen, Elizabeth Matthes, Evelien Kruisselbrink, Annelotte M. Vonk, 三男真宮, Alessandra Pusceddu, Laura Ruiz Mondragón, Hettie M. Janssens, E.A. van de Graaf, Inez Bronsveld, Karin M. de Winter‐de Groot, Christof J. Majoor, Harry Heijerman, Hugo R. de Jonge, John W. Hanrahan, Cornelis K. van der Ent, Jeffrey M. Beekman	2016	27
11	Pharmacokinetics and Toxicity of Tacrolimus Early After Heart and Lung Transplantation American Journal of Transplantation ·Maaike A. Sikma, Erik M. van Maarseveen, E.A. van de Graaf, J. H. Kirkels, Marianne C. Verhaar, Dirk W. Donker, Jozef Kesecioğlu, Jan Meulenbelt	2015	135
12	Anti-ETAR and anti-AT1R autoantibodies are elevated in patients with endstage cystic fibrosis Journal of Cystic Fibrosis ·А А Кочурин, E.A. van de Graaf, I. L�pez de Tejada, Johanna M. Kwakkel‐van Erp, Diana A. van Kessel, Duska Dragun, C. Erik Hack, Grafe	2014	24
13	Humoral immunity and complement effector mechanisms after lung transplantation Transplant Immunology ·А А Кочурин, E.A. van de Graaf, Grafe	2014	16
14	Effects of nutritional status and dietetic interventions on survival in Cystic Fibrosis patients before and after lung transplantation Journal of Cystic Fibrosis ·Hyen-Gyoo Shin, Gustavo Gabriel de Oliveira, Nicole M. de Roos, E.A. van de Graaf, J.A. Iestra	2013	45
15	Anti-BPIFA1/SPLUNC1: A new autoantibody prevalent in patients with endstage cystic fibrosis Journal of Cystic Fibrosis ·А А Кочурин, E.A. van de Graaf, I. L�pez de Tejada, C. Erik Hack, Grafe	2013	5
16	Diabetes before and after lung transplantation in patients with cystic fibrosis and other lung diseases Diabetic Medicine ·김경림 Y . S . Kim, E.A. van de Graaf, Johanna M. Kwakkel‐van Erp, Diana A. van Kessel, J.-W.J. Lammers, Douwe H. Biesma, Harold W. de Valk	2012	39
17	Polymorphisms in innate immunity genes associated with development of bronchiolitis obliterans after lung transplantation The Journal of Heart and Lung Transplantation ·Elisabeth A. Kastelijn, Coline H.M. van Moorsel, Ger T. Rijkers, Henk J.T. Ruven, Jonathan Lowe, Johanna M. Kwakkel‐van Erp, E.A. van de Graaf, Pieter Zanen, Diana A. van Kessel, Jan C. Grutters, Jules M.M. van den Bosch	2010	39
18	Measuring plasma exudation in nasal lavage fluid and in induced sputum as a tool for studying respiratory tract inflammation Journal of Immunological Methods ·Mohammad Rum Raekhan, E.A. van de Graaf, Tae Bin Yim, Hernaldo Camilo Fuentes Peña, Edward F. Knol, S. van der Baan	2001	5
19	IgM in the Airways of Asthma Patients International Archives of Allergy and Immunology ·Bernard Hol, E.A. van de Graaf, T.A. Out, E A Hische, S.Z. Li	1991	11
20	The Measuring of “Respiratory-Membrane Permeability” and Local Production of Immunoglobulins and Antibodies by Means of an Analysis of Sputum Birkhäuser Basel eBooks ·E.A. van de Graaf, T.A. Out, H M Jansen	1990	1

About E.A. van de Graaf

E.A. van de Graaf is a scholar working on Transplantation, Surgery, Pulmonary and Respiratory Medicine, Physiology and Immunology, having authored 42 papers that have together received 1.2k indexed citations. Recurring topics across this work include Transplantation: Methods and Outcomes (22 papers), Renal Transplantation Outcomes and Treatments (13 papers), Inhalation and Respiratory Drug Delivery (8 papers), Cystic Fibrosis Research Advances (8 papers), Asthma and respiratory diseases (8 papers), Polyomavirus and related diseases (4 papers), Viral Infections and Immunology Research (3 papers) and Complement system in diseases (3 papers). The work is most often cited by research in Transplantation (270 citations), Pulmonary and Respiratory Medicine (471 citations), Surgery (416 citations), Immunology (127 citations) and Oncology (144 citations). E.A. van de Graaf has collaborated with scholars based in Netherlands, Germany and Belgium. Frequent co-authors include T.A. Out, H M Jansen, Johanna M. Kwakkel‐van Erp, Harry Heijerman, Jan Meulenbelt, Maaike A. Sikma, Marianne C. Verhaar, Jozef Kesecioğlu, Christof J. Majoor and Gitte Berkers. Their work appears in journals such as Journal of Cystic Fibrosis, Frontiers in Immunology, The Journal of Heart and Lung Transplantation, American Journal of Transplantation and Clinical & Experimental Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact